My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
DIAZ-VALLE, D; MIGUELEZ SANCHEZ, R; FERNANDEZ ESPARTERO, MC and PASCUAL ALLEN, D. Treatment of refractory anterior diffuse escleritis with infliximab. Arch Soc Esp Oftalmol [online]. 2004, vol.79, n.8, pp.405-408. ISSN 0365-6691.
Case report: A 48-year old woman diagnosed with rheumatoid arthritis 10 years previously, developed severe anterior scleritis in the right eye (RE) refractory to conventional treatment. The patient was treated with 3 intravenous doses of Infliximab achieving complete remission of the scleral inflammation within four weeks. Discussion: The use of Infliximab, a blocker of tumour necrosis factor ( (TNF() could be an alternative approach to the management of refractory scleritis, but further long-term investigations would be necessary to evaluate their safety and efficacy.
Keywords : Refractory anterior escleritis; tumor necrosis factor; infliximab.